India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

 

Issue dated - 24th February 2005

Latest News

Aurobindo gets EDQM nod for domperidone and domperidone maleate
July 21st, 2005, 19:14:34 hrs IST
Symposium on patient safety and pharmacists to be held on July 27
July 21st, 2005, 16:59:13 hrs IST
Technology transfer conference on July 29-30
July 21st, 2005, 16:53:50 hrs IST
NICB acquires Ocimum\'s Biotracker LIMS
July 15th, 2005, 20:02:52 hrs IST
Ranbaxy gets FDA tentative approval for zidovudine generic
July 15th, 2005, 19:56:03 hrs IST

News Archives >>
Panacea lines up vaccine candidates and biopharmaceuticals
Orchid expects to triple growth in cephalosporins
Government decides to free trade from Rule 67 obligation
INSIDE PHARMA
PHARMA RESEARCH CONFLUENCE
EDIT
SPONSORS
CLINICAL RESEARCH & GCP WORKSHOP
PRE-CLINICAL RESEARCH
OPED
CORPORATE
TECHNOLOGY TRENDZ
HAPPENINGS
MARKETPLACE
HEALTH NEWS
IN THE NEWS
TRIPs
NANOTECH
NDDS
CONVERSATION

PHARMA RESEARCH CONFLUENCE
EDIT
Pharma World 2005

Editorial
Painful painkillers
Edit Article
Clinical trials: Will the boom sustain?

SPONSORS
CLINICAL RESEARCH & GCP WORKSHOP

Synchron: Leading in clinical trials and medical research services
Thermo Electron Corporation: Innovative technology leader


GCP review and quiz
Protocol group exercise
Importance of chirality in drug discovery
Informed consent process
PRE-CLINICAL RESEARCH
PRE-CLINICAL RESEARCH SEMINAR

IPR mediated opportunities in the pharma industry
The role of chemical development in drug development
Role of pharmacokinetics in drug discovery & development
Target selection in drug discovery

Preclinical toxicology evaluation
Risk management and insurance solutions in the Indian pharma industry

OPED
CORPORATE

Pre-clinical contract research — A market awaiting India

Galpha Labs to set up unit in Baddi
Strides, Stada conclude development and supply agreement for US
Avesthagen appoints new business heads
Biocon says oral insulin may become ‘blockbuster’

TECHNOLOGY TRENDZ
HAPPENINGS

Intelligent Drug Delivery Technologies: An outlook
Currently, the focus has been on novel or innovative drug delivery technologies that are intelligent enough to navigate the therapeutic molecule to the desired site, quickly and economically, say Vivek Ranjan Sinha, Jayant Rajaram Bhinge and Aman Trehan

AIDCOC, Millipore organise workshop on web and aseptic processing
IIPS workshop on int’l drug regulatory affairs in April
Book titled Scientific Foundation of Ayurveda unveiled

MARKETPLACE
HEALTH NEWS

Changing role of managers while jointly working with MRs
R K Srivastava reviews activities in the current scenario and also suggests various steps a manager should take while working jointly with medical representatives

Is India prepared for global medical tourism boom?
In recent years, India is being seen as an important player in the globally growing "Medical Tourism", which is projected as a new segment in travel and healthcare business. The former Indian finance minister Jaswant Singh envisaged to make India a "Global health destination" and the budget tabled by him included government policy for collaboration between the available medical expertise in the country and tourism industry.

IN THE NEWS
TRIPs

USP to establish site in India
Let quality be permeated, not controlled: Ace BioMed

TRIPs impact on R&D: Facts, facets and implications for Indian pharma industry
The post-TRIPs scenario offers a viable option in terms of partnerships with MNCs, which indigenous firms need to capitalise upon, say Mohd. Arif Khan, Imran Parvez, Anand Sharma and Parikshit Bansal

NANOTECH
NDDS

Nanosuspension drug delivery: Technology and application
Poorly soluble and low bioavailablity drugs so called ‘brick dust’ candidates once abandoned from formulation development work can be rescued with nanosuspension technology says Kirupakar B R

Biotin binding proteins: Concepts and role in targeted drug delivery
Drug targeting using biotin binding proteins may hold the answer for drugs which have not been able to show their effects because they cannot gather in effective concentrations at the target, say Aditya Pattani and Manan Desai

CONVERSATION

‘‘GCP culture is the key to success in clinical research’’
Brijesh Regal, the founder – CEO of Apothecaries Limited and an M Pharm from Delhi University, has vast experience of organising clinical trials in various therapeutic areas for some of the major global pharmaceutical giants. In an exclusive interview, Regal tells Jayashree Padmini that quality is a non-negotiable issue in clinical research. Excerpts:


<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 

© Copyright 2001: Indian Express Newspapers (Bombay) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Bombay) Limited. Site managed by BPD.